Skip Navigation



ToxSci Advance Access published online on November 8, 2006

Toxicological Sciences, doi:10.1093/toxsci/kfl162
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
95/2/452    most recent
kfl162v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Matthew, H. W.
Right arrow Articles by Smith, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matthew, H. W.
Right arrow Articles by Smith, M. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2006.
Received August 23, 2006
Accepted November 1, 2006

Reproductive and Developmental Toxicology

Perfluorooctanoic acid (PFOA) and Perfluorononanoic acid (PFNA) in Fetal and Neonatal Mice Following In Utero Exposure to 8-2 Fluorotelomer Alcohol (FTOH)

Henderson W. Matthew 1 * and Mary Alice Smith 2

1 Interdisciplinary Toxicology Program, College of Public Health, University of Georgia, Athens, GA 30602; National Exposure Research Laboratory, U. S. Environmental Protection Agency, Athens, GA 30605
2 Interdisciplinary Toxicology Program, College of Public Health, University of Georgia, Athens, GA 30602; Center for Food Safety, College of Agricultural and Environmental Sciences, University of Georgia, Athens, GA 30602

* To whom correspondence should be addressed.
Henderson W. Matthew, E-mail: Henderson.matt{at}epa.gov


   Abstract

8-2 fluorotelomer alcohol (FTOH) and its metabolites, perfluorooctanoic acid (PFOA) and perfluorononanoic acid (PFNA), are developmental toxicants, but metabolism and distribution during pregnancy is not known. To examine this, timed-pregnant mice received a single gavage dose (30 mg 8-2 FTOH/kg BW) on gestational day (GD) 8. Maternal and neonatal serum and liver as well as fetal and neonatal homogenate extracts were analyzed using GC/MS. During gestation (GD9 to GD18), maternal serum and liver concentrations of PFOA decreased from 789±41 to 668±23 ng/mL and from 673±23 to 587±55 ng/g, respectively. PFOA was transferred to the developing fetuses as early as 24 hours post-treatment with concentrations increasing from 45±9 ng/g (GD10) to 140±32 ng/g (GD18), while PFNA was quantifiable only at GD18 (31±4 ng/g). Post-partum, maternal serum PFOA concentrations decreased from 451±21 ng/mL post-natal day (PND) 1 to 52±19 ng/mL (PND15) and PFNA concentrations, although 5-fold less, exhibited a similar trend. Immediately after birth, pups were cross-fostered with dams that had been treated during gestation with 8-2 FTOH (T) or vehicle (C) resulting in four treatment groups in which the first letter represents in utero (fetal) exposure and the second represents lactational (neonatal) exposure: C/C, T/C, C/T, T/T. On PND1, neonatal whole-body homogenate concentrations of PFOA from T/T and T/C groups averaged 200±26 ng/g, decreased to 149±19 ng/g at PND3 and this decreasing trend was seen in both neonatal liver and serum from PND3 to PND15. Based on detectible amounts of PFOA in neonatal serum in the C/T group on PND3 (57±11 ng/mL) and on PND15 (58±3 ng/mL), we suggest the neonates were exposed through lactation. In conclusion, exposure of neonates to PFOA and PFNA occur both pre- and post-natally following maternal 8-2 FTOH exposure on GD8.

Keywords: Fluorotelomer alcohols (FTOH); PFOA; PFNA; fetal and neonatal distribution.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
A. J. Nilsen, M. A. Landin, K. H. Haug, F. Fonnum, U. Berger, and H. Osmundsen
Comparative hepatic gene expression profiling of rats treated with 1H,1H,2H,2H-heptadecafluorodecan-1-ol or with pentadecafluorooctanoic acid
Physiol Genomics, August 1, 2008; 34(3): 285 - 303.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
C. Fei, J. K. McLaughlin, R. E. Tarone, and J. Olsen
Fetal Growth Indicators and Perfluorinated Chemicals: A Study in the Danish National Birth Cohort
Am. J. Epidemiol., July 1, 2008; 168(1): 66 - 72.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Lau, K. Anitole, C. Hodes, D. Lai, A. Pfahles-Hutchens, and J. Seed
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Toxicol. Sci., October 1, 2007; 99(2): 366 - 394.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.